These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1129 related items for PubMed ID: 27911427

  • 1. [Modern approach to early diagnosis and pathogenetic treatment of diabetic retinopathy].
    Vorob'eva IV.
    Vestn Oftalmol; 2016; 132(5):60-67. PubMed ID: 27911427
    [Abstract] [Full Text] [Related]

  • 2. Optical coherence tomography for the detection of early macular edema in diabetic patients with retinopathy.
    Koleva-Georgieva DN, Sivkova NP.
    Folia Med (Plovdiv); 2010; 52(1):40-8. PubMed ID: 20380286
    [Abstract] [Full Text] [Related]

  • 3. [Results of the use of antioxidant and angioprotective agents in type 2 diabetes patients with diabetic retinopathy and age-related macular degeneration].
    Moshetova LK, Vorob'eva IV, Alekseev IB, Mikhaleva LG.
    Vestn Oftalmol; 2015; 131(3):34-44. PubMed ID: 26310005
    [Abstract] [Full Text] [Related]

  • 4. Types of diabetic macular edema assessed by optical coherence tomography.
    Koleva-Georgieva DN, Sivkova NP.
    Folia Med (Plovdiv); 2008; 50(3):30-8. PubMed ID: 19009748
    [Abstract] [Full Text] [Related]

  • 5. Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation.
    Vujosevic S, Bottega E, Casciano M, Pilotto E, Convento E, Midena E.
    Retina; 2010 Jun; 30(6):908-16. PubMed ID: 20168272
    [Abstract] [Full Text] [Related]

  • 6. Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment.
    Reznicek L, Cserhati S, Seidensticker F, Liegl R, Kampik A, Ulbig M, Neubauer AS, Kernt M.
    Acta Ophthalmol; 2013 Nov; 91(7):e529-36. PubMed ID: 23647578
    [Abstract] [Full Text] [Related]

  • 7. Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients.
    Kim JT, Lee DH, Joe SG, Kim JG, Yoon YH.
    Invest Ophthalmol Vis Sci; 2013 May 09; 54(5):3378-84. PubMed ID: 23611988
    [Abstract] [Full Text] [Related]

  • 8. Diabetic macular edema: fundus autofluorescence and functional correlations.
    Vujosevic S, Casciano M, Pilotto E, Boccassini B, Varano M, Midena E.
    Invest Ophthalmol Vis Sci; 2011 Jan 21; 52(1):442-8. PubMed ID: 20720226
    [Abstract] [Full Text] [Related]

  • 9. Choroidal Variations in Diabetic Macular Edema: Fluorescein Angiography and Optical Coherence Tomography.
    Wang X, Li S, Li W, Hua Y, Wu Q.
    Curr Eye Res; 2018 Jan 21; 43(1):102-108. PubMed ID: 28937826
    [Abstract] [Full Text] [Related]

  • 10. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
    Kook D, Wolf A, Kreutzer T, Neubauer A, Strauss R, Ulbig M, Kampik A, Haritoglou C.
    Retina; 2008 Oct 21; 28(8):1053-60. PubMed ID: 18779710
    [Abstract] [Full Text] [Related]

  • 11. Macular thickness measured by optical coherence tomography (OCT) in diabetic patients.
    Lattanzio R, Brancato R, Pierro L, Bandello F, Iaccher B, Fiore T, Maestranzi G.
    Eur J Ophthalmol; 2002 Oct 21; 12(6):482-7. PubMed ID: 12510717
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema.
    Writing Committee for the Diabetic Retinopathy Clinical Research Network, Fong DS, Strauber SF, Aiello LP, Beck RW, Callanan DG, Danis RP, Davis MD, Feman SS, Ferris F, Friedman SM, Garcia CA, Glassman AR, Han DP, Le D, Kollman C, Lauer AK, Recchia FM, Solomon SD.
    Arch Ophthalmol; 2007 Apr 21; 125(4):469-80. PubMed ID: 17420366
    [Abstract] [Full Text] [Related]

  • 15. Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study.
    Ribeiro ML, Seres AI, Carneiro AM, Stur M, Zourdani A, Caillon P, Cunha-Vaz JG, DX-Retinopathy Study Group.
    Graefes Arch Clin Exp Ophthalmol; 2006 Dec 21; 244(12):1591-600. PubMed ID: 16763797
    [Abstract] [Full Text] [Related]

  • 16. One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema.
    Do DV, Nguyen QD, Boyer D, Schmidt-Erfurth U, Brown DM, Vitti R, Berliner AJ, Gao B, Zeitz O, Ruckert R, Schmelter T, Sandbrink R, Heier JS, da Vinci Study Group.
    Ophthalmology; 2012 Aug 21; 119(8):1658-65. PubMed ID: 22537617
    [Abstract] [Full Text] [Related]

  • 17. Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema.
    Sun JK, Lin MM, Lammer J, Prager S, Sarangi R, Silva PS, Aiello LP.
    JAMA Ophthalmol; 2014 Nov 21; 132(11):1309-16. PubMed ID: 25058813
    [Abstract] [Full Text] [Related]

  • 18. Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy.
    Massin P, Duguid G, Erginay A, Haouchine B, Gaudric A.
    Am J Ophthalmol; 2003 Feb 21; 135(2):169-77. PubMed ID: 12566020
    [Abstract] [Full Text] [Related]

  • 19. Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema.
    Solaiman KA, Diab MM, Abo-Elenin M.
    Retina; 2010 Feb 21; 30(10):1638-45. PubMed ID: 20838357
    [Abstract] [Full Text] [Related]

  • 20. The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema.
    Do DV, Schmidt-Erfurth U, Gonzalez VH, Gordon CM, Tolentino M, Berliner AJ, Vitti R, Rückert R, Sandbrink R, Stein D, Yang K, Beckmann K, Heier JS.
    Ophthalmology; 2011 Sep 21; 118(9):1819-26. PubMed ID: 21546089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.